Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

5-Amino-1MQ (10 mg Vial) Dosage Protocol

5-Amino-1MQ (10 mg Vial) Dosage Protocol 5-Amino-1MQ Dosage Chart 5-Amino-1MQ is dosed at 2.5 mg–5 mg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 5 mg/mL. This information is for

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

5-Amino-1MQ (10 mg Vial) Dosage Protocol

5-Amino-1MQ Dosage Chart

5-Amino-1MQ is dosed at 2.5 mg–5 mg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 5 mg/mL. This information is for research and educational use only.

Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration.

Typical daily range: 2.5–5 mg once or twice daily (subcutaneous).

Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks[4].

5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels[1][2]. By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency[3]. This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 10 mg vial format.

Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read 5-Amino-1MQ Peptide: Benefits, Uses, Side Effects, Dosage, and Research.

Subcutaneous Protocol (2 mL = 5 mg/mL)

Days 1–2 (Tolerance)

2.5 mg (2500 mcg)

50 units (0.50 mL)

Days 3+ (Standard)

5 mg (5000 mcg)

100 units (1.00 mL)

Alternative BID

2.5 mg twice daily

50 units (0.50 mL) × 2

Frequency: Inject once or twice daily subcutaneously. Due to the compound’s plasma half-life of approximately 3.8–6.9 hours[5], twice-daily (BID) dosing may provide more sustained NNMT inhibition. A single 10 mg vial provides 2–4 days of material at these doses.

Reconstitution Steps

Remove the vial from freezer storage (−20 °C / −4 °F) and allow to equilibrate at room temperature for 15–20 minutes.

Draw 2.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved—solution should be clear (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 2–4 weeks.

Supplies Needed

Plan based on protocol duration using the 10 mg vial format at 5 mg/day.

1 week (5 mg/day = 35 mg total) → 4 vials

2 weeks (5 mg/day = 70 mg total) → 7 vials

4 weeks (5 mg/day = 140 mg total) → 14 vials

1 week (once daily): 7 syringes

2 weeks (once daily): 14 syringes

4 weeks (once daily): 28 syringes

1 week (4 vials × 2.0 mL = 8 mL) → 1 × 10 mL bottle

2 weeks (7 vials × 2.0 mL = 14 mL) → 2 × 10 mL bottles

4 weeks (14 vials × 2.0 mL = 28 mL) → 3 × 10 mL bottles

1 week (once daily): 14 swabs

2 weeks (once daily): 28 swabs

4 weeks (once daily): 56 swabs → recommend 1 × 100-count box

Protocol Overview

Concise summary of the subcutaneous regimen.

Goal: Support metabolic efficiency through NNMT inhibition, potentially enhancing fat oxidation and NAD+ levels[1][2].

Schedule: Daily subcutaneous injections; each 10 mg vial provides 2–4 days of material.

Dose Range: 2.5–5 mg once or twice daily.

Reconstitution: 2.0 mL per 10 mg vial (5 mg/mL) for accurate measurements.

Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F).

Dosing Protocol

Suggested approach for the 10 mg vial format.

Start: 2.5 mg once daily to assess tolerance.

Target: 5 mg once daily or 2.5 mg twice daily (BID).

Frequency: Once or twice per day (subcutaneous).

Vial Duration: Single 10 mg vial lasts 2–4 days at standard doses.

Timing: Morning administration preferred; BID dosing may be split AM/PM.

Storage Instructions

Proper storage preserves compound stability.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable up to 24 months[4].

Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks.

Allow vials to reach room temperature before reconstitution to prevent condensation and pressure issues.

Do not refreeze reconstituted solution.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each administration; dispose in a sharps container[6].

Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[7].

Inject slowly; a mild stinging sensation may occur due to the quinolinium structure.

Document daily dose and site rotation to maintain consistency.

The 10 mg vial format requires multiple vials for extended protocols; plan supplies accordingly.

How This Works

5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small molecule that selectively inhibits Nicotinamide N-methyltransferase (NNMT)[1]. NNMT is a cytosolic enzyme that methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a methyl donor. In states of obesity and metabolic dysfunction, NNMT is often overexpressed in adipose tissue, depleting nicotinamide and reducing NAD+ availability[2].

By inhibiting NNMT, 5-Amino-1MQ may spare nicotinamide for NAD+ synthesis via the salvage pathway, thereby activating SIRT1 (Sirtuin 1) pathways associated with mitochondrial biogenesis, fat oxidation, and metabolic flexibility[3]. Preclinical studies indicate that NNMT knockdown or inhibition can protect against diet-induced weight gain and improve metabolic parameters without reducing food intake[8][9].

Potential Benefits & Side Effects

Observations from preclinical and early research literature.

May support reductions in fat mass while preserving lean muscle in animal models[8][9].

Associated with elevated NAD+ levels and SIRT1 activation in preclinical studies[2][3].

Enhanced grip strength observed in aged mice when combined with exercise[10].

Generally well tolerated; occasional reports of mild headache, transient jitteriness, or injection-site reactions.

Long-term human safety data not established; this compound remains investigational.

Lifestyle Factors

Complementary strategies for best outcomes.

Pair with a balanced, protein-forward diet tailored to energy needs.

Combine resistance training and aerobic activity—preclinical data suggest synergy with exercise[10].

Prioritize sleep and stress management to support metabolic adaptation.

Consider complementary NAD+ precursors (NMN/NR) per emerging stack protocols[11].

Injection Technique

General subcutaneous guidance from clinical best-practice resources[6].

Clean the vial stopper and skin with alcohol; allow to dry.

Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[12][13].

Do not aspirate for subcutaneous injections; inject slowly and steadily[12].

Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[7].

Slow injection may minimize any stinging sensation associated with the compound.

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

References

Nature Medicine (2014) — Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity View Source

PMC (2024) — Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunctions View Source

Frontiers in Pharmacology (2024) — NNMT: a novel therapeutic target for metabolic syndrome View Source

Creative Peptides — Peptide stability and storage guidelines for lyophilized compounds View Source

PubMed (2021) — LC-MS/MS assay for 5-amino-1-methylquinolinium: pharmacokinetic and oral bioavailability study View Source

PMC — Subcutaneous drug injection review: pharmacologic considerations View Source

NCBI Bookshelf — Best practices for injection (asepsis, preparation, and administration) View Source

ResearchGate (2021) — Combined NNMT inhibition and reduced-calorie diet normalizes body composition in obese mice View Source

PMC (2022) — Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice View Source

Scientific Reports / NMN.com — Role of NNMT inhibition in muscle strength: enhanced grip strength with exercise View Source

Swolverine — 5-Amino-1MQ mechanism, benefits, stacking and cycling guide View Source

CDC — Vaccine administration: subcutaneous route (angle/site; no aspiration) View Source

CDC (Subcut Injection PDF) — Technique diagram and site guidance for subcutaneous injections View Source

Additional Research and Background

These sources provide related context and are not presented as support for a specific statement above.

Journal of Medicinal Chemistry (ACS) — Bisubstrate inhibitors of NNMT with enhanced activity View Source

Related research, protocols, and guides

Explore the available research context, protocol variants or comparisons, and practical guides. When vial-size variants exist, they remain separate because vial strength, concentration, and syringe-unit calculations can differ. Related compounds and blends are comparisons only, not interchangeable.

Research overview

5-Amino-1MQ Peptide: Benefits, Uses, Side Effects, Dosage, and Research

Other vial-size protocols

5-Amino-1MQ (50 mg Vial) Dosage Protocol

Practical guides

Single Peptide Dosages

Peptide Dosage & Reconstitution Calculator

How to Reconstitute Peptides

Syringe & Measurement Guide

Peptide Storage Guide

Peptide Dosage Chart

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Cortexin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Cortexin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
02Amycretin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Amycretin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
03VK2735 — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. VK2735 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
04Thymogen — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Thymogen is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
05Davunetide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Davunetide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
Research context

Read sources and limitations before applying a claim.

Did the impressive cognition study use Sermorelin?

No — and this is a crucial distinction. The randomized controlled trial that found improved executive function in older adults used tesamorelin, a stabilized, longer-acting GHRH analog dosed at 1 mg daily, not Sermorelin.5 The two share the GHRH mechanism but differ in stability and duration of action. The result supports the idea that GHRH-receptor stimulation may benefit cognition; it does not establish that Sermorelin specifically reproduces that effect.

Source: dosagepeptide.com ↗

Why EPO draws research interest

These are the directions researchers and the peptide community most often explore EPO for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

Source: dosagepeptide.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Oxytocin Dosage Chart

Oxytocin is dosed at 100 mcg–500 mcg daily in educational protocols, administered subcutaneously or intranasally. A 10 mg vial reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only. Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration. Typical daily range: 100–500 mcg once daily (gradual titration). Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe. Storage: Lyophilized: freeze at −20 °C (−4 °F) or refrigerate at 2–8 °C (35.6–46.4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 28–30 days. Oxytocin is a peptide hormone (nonapeptide) known for its role in childbirth and lactation, and it also influences social bonding and behavior[1]. In research settings, synthetic oxytocin is used to explore effects ranging from stress and anxiety to social cognition[2]. Oxytocin 10 mg is available as a lyophilized powder for research use[3], requiring reconstitution before dosing. This protocol compiles evidence‑based guidance on dosing, administration, and storage for oxytocin peptide. Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Oxytocin Peptide: Benefits, Uses, Side Effects, Dosage, and Research.

Source: peptidedosages.com ↗
Storage reference

Storage Instructions

Proper storage preserves compound stability. Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable up to 24 months. Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks. Allow vials to reach room temperature before reconstitution to prevent condensation and pressure issues. Do not refreeze reconstituted solution.

Source: peptidedosages.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →